Oluwaseun O Ojo
Overview
Explore the profile of Oluwaseun O Ojo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
395
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Movassagh H, Ojo O, Mohammed A, Shan L, Halayko A, Gounni A
Am J Respir Cell Mol Biol
. 2019 May;
60(5):601-603.
PMID: 31042085
No abstract available.
2.
Ojo O, Ryu M, Jha A, Unruh H, Halayko A
Am J Physiol Lung Cell Mol Physiol
. 2015 Oct;
309(11):L1354-66.
PMID: 26432865
High mobility group box 1 (HMGB1) is a damage-associated molecular pattern (DAMP) protein that binds Toll-like receptors (e.g., TLR4) and the receptor for advanced glycated end products (RAGE). The direct...
3.
Anaparti V, Ilarraza R, Orihara K, Stelmack G, Ojo O, Mahood T, et al.
Am J Physiol Lung Cell Mol Physiol
. 2015 Apr;
308(12):L1253-64.
PMID: 25888577
Human airway smooth muscle (HASM) exhibits enhanced contractility in asthma. Inflammation is associated with airway hypercontractility, but factors that underpin these features are not fully elucidated. Glutamate toxicity associated with...
4.
Ryu M, Jha A, Ojo O, Mahood T, Basu S, Detillieux K, et al.
Am J Physiol Lung Cell Mol Physiol
. 2014 Sep;
307(10):L765-74.
PMID: 25217661
Emerging epidemiological evidence reveals a link between lung disease and exposure to indoor pollutants such as perfluorinated compounds (PFCs). PFC exposure during critical developmental stages may increase asthma susceptibility. Thus,...
5.
Ghavami S, Sharma P, Yeganeh B, Ojo O, Jha A, Mutawe M, et al.
Biochim Biophys Acta
. 2014 Mar;
1843(7):1259-71.
PMID: 24637330
HMG-CoA reductase, the proximal rate-limiting enzyme in the mevalonate pathway, is inhibited by statins. Beyond their cholesterol lowering impact, statins have pleiotropic effects and their use is linked to improved...
6.
Siddiqui S, Redhu N, Ojo O, Liu B, Irechukwu N, Billington C, et al.
Pulm Pharmacol Ther
. 2012 Sep;
26(1):132-44.
PMID: 22981423
Asthma is characterized in part by variable airflow obstruction and non-specific hyperresponsiveness to a variety of bronchoconstrictors, both of which are mediated by the airway smooth muscle (ASM). The ASM...
7.
Wright D, Trian T, Siddiqui S, Pascoe C, Johnson J, Dekkers B, et al.
Pulm Pharmacol Ther
. 2012 Sep;
26(1):42-9.
PMID: 22939888
The biological responses of airway smooth muscle (ASM) are diverse, in part due to ASM phenotype plasticity. ASM phenotype plasticity refers to the ability of ASM cells to change the...
8.
Wright D, Trian T, Siddiqui S, Pascoe C, Ojo O, Johnson J, et al.
Pulm Pharmacol Ther
. 2012 Aug;
26(1):95-104.
PMID: 22921313
In asthma, the airway smooth muscle (ASM) cell plays a central role in disease pathogenesis through cellular changes which may impact on its microenvironment and alter ASM response and function....
9.
Billington C, Ojo O, Penn R, Ito S
Pulm Pharmacol Ther
. 2012 May;
26(1):112-20.
PMID: 22634112
Agonists activating β(2)-adrenoceptors (β(2)ARs) on airway smooth muscle (ASM) are the drug of choice for rescue from acute bronchoconstriction in patients with both asthma and chronic obstructive pulmonary disease (COPD)....
10.
Mahn K, Ojo O, Chadwick G, Aaronson P, Ward J, Lee T
Thorax
. 2010 Jun;
65(6):547-52.
PMID: 20522856
Asthma is characterised by airway hyper-responsiveness and remodelling, and there is mounting evidence that alterations in the phenotype of airway smooth muscle (ASM) play a central role in these processes....